Stay updated on Pembrolizumab in MPM Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in MPM Clinical Trial page.

Latest updates to the Pembrolizumab in MPM Clinical Trial page
- Check5 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, signaling a small metadata update to the study record without altering substantive information.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page now indicates that recruitment has ended for participants. It adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment header formatting, with the revision noted as v3.6.0.SummaryDifference0.3%

- Check26 days agoChange DetectedPage revision updated from v3.5.4 to v3.5.5, signaling a minor site update. This does not modify the study content or how users interact with the page.SummaryDifference0.0%

- Check48 days agoChange DetectedPage revision updated from v3.5.3 to v3.5.4. This indicates the study record has been updated to a newer revision of the page content.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3. This reflects a platform release rather than a change to the clinical trial study content.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in MPM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MPM Clinical Trial page.